NIH-funded research Fellowship grant

Investigating how FOXK proteins affect KSHV infection

Official title: Role of FOXK subfamily in KSHV infection

Funded at University of Florida · NIH-10997917 · Data updated 2026-11-12

This study is looking at how certain proteins called FOXK help the Kaposi's sarcoma-associated herpesvirus (KSHV) behave, which could lead to better ways to treat diseases linked to this virus, like Kaposi's sarcoma.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startAugust 16, 2024
Project endAugust 15, 2027
Funding year2024
Award (this year)$44,982
NIH project number1F31DE034303-01
Project IDNIH-10997917 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals affected by KSHV-related diseases, such as Kaposi's sarcoma or primary effusion lymphoma.

Less likely to help

Patients who do not have KSHV-related diseases or are not infected with KSHV may not benefit from this research.

What this research studies

This research focuses on understanding the role of FOXK proteins in the lifecycle of Kaposi's sarcoma-associated herpesvirus (KSHV), which is linked to several diseases including Kaposi's sarcoma. The study will explore how these proteins interact with KSHV's immediate early proteins during the virus's lytic reactivation phase. By using advanced techniques such as co-immunoprecipitation and imaging analysis, researchers aim to identify the mechanisms by which FOXK proteins influence KSHV infection and its associated diseases. This could lead to new insights into potential therapeutic targets for managing KSHV-related conditions.

Why it matters

Potential benefit: If successful, this research could lead to new treatment strategies for diseases associated with KSHV, improving patient outcomes.

How similar studies have gone: While the specific role of FOXK proteins in KSHV infection is not well-studied, similar research approaches have shown promise in understanding viral interactions with host cellular mechanisms.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Palmer, Marley — University of Florida
  • Study coordinator: Palmer, Marley

Related research

Other NIH-funded projects on the same topics.

  • Mitochondrial pores and muscle loss in cancer cachexia

    A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.

    NIH research University of Florida · Gainesville, United States · NIH-11636110

  • Photobiomodulation for jaw pain from TMD

    A clinician-scientist at the University of Florida is testing a light-based therapy to help adults with temporomandibular disorder pain feel better and jaw function improve.

    NIH research University of Florida · Gainesville, United States · NIH-11635590

  • How the brain controls swallowing and airway protection

    A research team at the University of Florida is studying how brain networks control swallowing to reduce risk of choking and lung infections in people with neuromuscular diseases.

    NIH research University of Florida · Gainesville, United States · NIH-11630949

  • Donor-driven 3D organoid platform to study pancreatic cancer drug response

    A pilot project to create patient-derived, 3D organoid models of pancreatic cancer to measure how tumors from different people respond to chemotherapy.

    NIH research University of Florida · Gainesville, United States · NIH-11625599

  • RAAS inhibitors and pancreatic cancer risk in diverse adults

    A Florida-based study will look at whether commonly used blood pressure medicines (RAAS inhibitors) are linked to new cases of pancreatic cancer, especially among Black and Hispanic adults.

    NIH research University of Florida · Gainesville, United States · NIH-11625597

  • Pilot project exploring new cancer drugs for pancreatic cancer in African American patients

    A small, early-stage project tests new drug-derived compounds to treat pancreatic cancer, focusing on African American patients who are disproportionately affected.

    NIH research University of Florida · Gainesville, United States · NIH-11625594

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.